[Editor’s note: Karl Haro von Mogel is a geneticist with a PhD in Plant Breeding and Plant Genetics from UW-Madison with a minor in Life Sciences Communication.]
On Tuesday [Nov. 14], I attended the FDA Biotech Education and Outreach public meeting in San Francisco, and here is my experience participating in this public event. I was happy to be able to make a comment on behalf of Biology Fortified….
…[The comments from the Center for Food Safety representative, Rebecca Spector, read] like they were drafted by lawyers, they also hint at the various ways that the anti-GMO law firm may work to attack and undermine any outreach program from the FDA.
[Editor’s note: Read the GLP’s profile on the Center for Food Safety]
Spector said that the industry “failed to produce a commercialized GE crop with enhanced nutritional content.” The Center for Food Safety spends its time suing to stop the approval of every genetically engineered crop that it can, is now complaining that none have come to market? Apparently they missed the approval of high-oleic Plenish soybeans by DuPont Pioneer (see our interview with Susan Knowlton here) and omega-3 fatty acid producing soybeans by Monsanto. I’m sure they just forgot about them.
The GLP aggregated and excerpted this article to reflect the diversity of news, opinion and analysis. Read full, original post: Making a difference at the FDA Biotech meeting